What is the role of dehydroepiandrosterone in gynecologic practice?

Authors :: Gajarawala, Shilpa N.
Wood, Tiffany A.
Stanton, Amanda P.
Source :: JAAPA: Journal of the American Academy of Physician Assistants (Lippincott Williams & Wilkins); Dec2019, Vol. 32 Issue 12, p11-12, 2p
Publication Year :: 2019
Abstract: In small clinical trials, dehydroepiandrosterone (DHEA) has been found to relieve symptoms associated with postmenopausal conditions and infertility in women. DHEA may provide a cost-effective alternative to typical hormone therapies. Because of a lack of long-term and large-scale studies, only intravaginal DHEA supplementation is approved and recommended for treatment. Further investigation of DHEA supplementation is needed and encouraged to determine its safety and effectiveness. [ABSTRACT FROM AUTHOR]

Subjects :: COST effectiveness
DEHYDROEPIANDROSTERONE
DISEASES
GYNECOLOGY
HORMONES
INFERTILITY
MEDICAL practice
PATIENT safety
THERAPEUTICS
VAGINAL medication
WOMEN'S health
TREATMENT effectiveness
POSTMENOPAUSE
SYMPTOMS

Language :: English
ISSN :: 15471896
Volume :: 32
Issue :: 12
Database :: Complementary Index
Journal :: JAAPA: Journal of the American Academy of Physician Assistants (Lippincott Williams & Wilkins)
Publication Type :: Academic Journal
Accession number :: 144269671
Full Text :: https://doi.org/10.1097/01.JAA.0000604888.50734.64